Press release

Invitation to presentation of the Q3 report 2023

November 01, 2023

STOCKHOLM – November 1, 2023 – Oncopeptides AB (publ), a biotech company focused on difficult-to-treat cancers, will publish the report for the third quarter 2023 at 08:00 CET on November 8. Investors, financial analysts, and media are invited to participate in a webcast and a subsequent Q&A session on November 8 at 09:00 CET.

The presentation will be hosted by Sofia Heigis, CEO, together with Holger Lembrér, CFO. The webcast will be held in English and published on the website of Oncopeptides – www.oncopeptides.com – in conjunction with the start of the presentation.

Information for participants
If you wish to participate via webcast please use the link below.
https://ir.financialhearings.com/oncopeptides-q3-2023
 
If you wish to participate via teleconference please register on the link below. After registration you will be provided phone numbers and a conference ID to access the conference. You can ask questions verbally via the teleconference.
https://conference.financialhearings.com/teleconference/?id=5007314